Fever Q

From Zoophilia Wiki
Revision as of 01:29, 28 September 2024 by SockyPaws (talk | contribs) (Article cleanup and citation refreshing (incomplete; will return soon))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
IMPORTED FROM WIKIPEDIA
This article was originally imported from Wikipedia and as such may be partially or completely broken, filled with links to non-existent pages, contain/cite outdated information, and/or exhibit a tonal incongruence relative to our original content. We at the Zoophilia Wiki make every effort to ensure up-to-date information is provided here so that zoophiles may be well-informed, and will continue to edit the article until it is readable and useful to our audience. As the page begins to materially differ from the source document, this notice will eventually be removed.
The Zoophilia Wiki disclaims any liability for misinformation spread by the archiving of these articles.
Q fever
Other namesQuery fever, coxiellosis[1][2]
File:Immunohistochemical detection of Coxiella burnetii in resected cardiac valve of a 60-year-old man with Q fever endocarditis.jpg
Immunohistochemical detection of C. burnetii in a resected cardiac valve from a 60-year-old infected man from Cayenne, French Guiana, using monoclonal antibodies against C. burnetii and hematoxylin for staining. (Shown at 50x magnification)
Symptoms
Usual onset2–3 weeks
DurationApprox. 3 days when treated early, 2 weeks if left untreated
Types
CausesContact with infected livestock or other domestic mammals, their milk, urine, feces, vaginal mucus or semen[2]
Diagnostic methodIndirect fluorescent antibody test (ref. standard) or PCR assay for more rapid results
Differential diagnosis[2]
Treatmenttwo-week course of oral antibiotics
Medication
Prognosis
  • Acute:  full recovery
  • Chronic: 10% mortality when treated, otherwise fatal

Q fever or query fever is a disease caused by infection with the obligate intracellular pathogenic parasite Coxiella burnetii,[1][3][4] a Gram-negative bacterium that affects humans and other animals. This organism is uncommon, but may be found in cattle, sheep, goats and other domestic mammals—including cats and dogs. The infection results from inhalation of a spore-like small-cell variant of the pathogen or from direct contact with the milk, urine, feces, vaginal mucus or semen of infected animals, with an incubation period of 9–40 days. Rarely, the disease is tick-borne.[5]

Signs and symptoms

The typical incubation period is between two to three weeks.[6] Common presentations include flu-like symptoms with an abrupt onset of fever, chills, profuse perspiration, malaise, severe headache, muscle and joint pain, loss of appetite, upper respiratory tract problems, a dry cough, pleuritic pain, confusion, nausea and gastroenteritis. However, roughly half of infected individuals are asymptomatic.[6]

During its course, the disease can progress to an atypical, or "walking," pneumonia which can result in life-threatening acute respiratory distress syndrome (ARDS), with such symptoms usually occurring during the first four to five days of infection.[citation needed]

Less often, Q fever causes granulomatous (chronic) hepatitis, which may be asymptomatic or becomes symptomatic with malaise, fever, liver enlargement and abdominal right upper quadrant pain. Elevated transaminase (liver enzymes) values are common, however jaundice is not. Retinal vasculitis is also a known symptom, though rare.[7]

The chronic form of Q fever is virtually identical to endocarditis (inflammation of the inner lining of the heart, often involving the heart valves, as well)[8] and can occur months or decades following the initial infection. It is usually fatal if left untreated, but with appropriate treatment the mortality rate falls to roughly 10%.[citation needed]

Diagnosis

File:Q fever management algorithm.gif
Q fever management algorithm from the CDC.

Several aspects of the disease make diagnosis of Q fever a difficult and lengthy process, usually relying on serology,[9][10] after the onset of symptoms. The reference standard is an indirect fluorescent antibody (IFA) test to look for an immunoglobulin G (IgG) response to the infection, performed on paired serum samples taken at least two weeks apart. A fourfold or greater rise in antibody titers is needed for a positive result, with accuracy increasing commensurate to the interval between when the samples are taken, three to six weeks being optimal. Antibodies to C. burnetii tend to remain elevated for many months and sometimes even years after the disease has resolved. Statistical sampling suggests that approximately 3% of healthy adults in the U.S. and up to 20% of people in high-risk professions—veterinarians, ranchers, etc.—have elevated titers from past Q fever infections, though the large majority of those prior infections will have been asymptomatic, and thus, untreated.[11]

If a more rapid determination of Q fever infection is needed during the acute phase of the illness (such as when a differential diagnosis cannot exclude other, more serious potential causes), a polymerase chain reaction (PCR) assay can be performed on a sample of whole blood—or serum, at some laboratories—to detect the presence of C. burnetii DNA sequences at the molecular level. This method is most sensitive in the first week of illness, before the appearance of detectable levels of organism-specific antibodies, and is quickly rendered mostly ineffective following the start of standard treatment regimens. While a positive PCR result can be a key element in diagnosis, particularly for patients suffering an extreme course of symptoms, a negative result does not rule out the infection and a serological result should be determined afterwards for greater certainty.[11]

Diagnosis of the chronic form of the infection relies on the two distinct antigenic phases (I and II, corresponding to the more and less virulent forms of the pathogen, respectively) of human antibody responses. In acute infections, the phase II antigen will be predominant, due to a combination of natural immune response as well as the necessary delay between patient samples for the test comparison. However, the reverse is true for chronic infections, which are associated with a rising phase I IgG titer (≥1:210)—potentially higher than even phase II—showing the failure of the immune system to arrest the progression of the disease as expected.[11]

Looking for the bacteria themselves in blood via culture isolation is both technically difficult and time consuming, and only available at specialized microbiology laboratories, making it ill-suited for routine diagnoses; common hospital blood cultures are unable to detect the organism.[11]

When Q fever causes endocarditis, transesophageal echocardiography may be required to properly diagnose it. Q fever hepatitis manifests as an elevation of alanine transaminase and aspartate transaminase, but a definitive diagnosis is only possible on liver biopsy, which shows the characteristic fibrin ring granulomas.[12]

Prevention

Prophylactic protection is possible with the use of Q-Vax: a whole-cell, inactivated vaccine developed by Australian vaccine manufacturer CSL Limited.[13] The intradermal vaccination is composed of killed C. burnetii organisms. Skin and blood tests should be done before vaccination to identify pre-existing immunity, because vaccinating people who already have an immunity can result in a severe local reaction. After a single dose of vaccine, protective immunity lasts for many years. Revaccination is not generally required. Annual screening is typically recommended.[14]

In 2001, Australia introduced a national Q fever vaccination program for people working in “at risk” occupations. Vaccinated or previously exposed people may have their status recorded on the Australian Q Fever Register,[15] which may be a condition of employment in the meat processing industry or in veterinary research.[16] An earlier killed vaccine had been developed in the Soviet Union, but its side effects prevented its licensing abroad.[citation needed]

Preliminary results suggest vaccination of animals may be a method of control. Published trials proved that use of a registered phase vaccine (Coxevac) on infected farms is a tool of major interest to manage or prevent early or late abortion, repeat breeding, anoestrus, silent oestrus, metritis, and decreases in milk yield when C. burnetii is the major cause of these problems.[17][18]

Treatment

Treatment of acute Q fever with antibiotics is very effective[citation needed] and should be given in consultation with an infectious diseases specialist.[citation needed] Commonly used antibiotics include doxycycline, tetracycline, chloramphenicol, ciprofloxacin, ofloxacin, and hydroxychloroquine. [citation needed]Chronic Q fever is more difficult to treat and can require up to four years of treatment with doxycycline and quinolones or doxycycline with hydroxychloroquine.[citation needed]Q fever in pregnancy is especially difficult to treat because doxycycline and ciprofloxacin are contraindicated in pregnancy. The preferred treatment is five weeks of co-trimoxazole.[19]

Epidemiology

File:Coxiella burnetii 01.JPG
C. burnetii, the Q fever-causing agent

The pathogenic agent is found worldwide, with the exception of New Zealand.[20] The bacterium is extremely sustainable and virulent: a single organism is able to cause an infection. The common source of infection is inhalation of contaminated dust, contact with contaminated milk, meat, or wool, and particularly birthing products. Ticks can transfer the pathogenic agent to other animals. Transfer between humans seems extremely rare and has so far been described in very few cases.[citation needed]

Some studies have shown more men to be affected than women,[21][22] which may be attributed to different employment rates in typical professions.[citation needed]

“At risk” occupations include:[23]

History

File:Pneumonia x-ray.jpg
Image A: A normal chest X-ray Image B: Q fever pneumonia

Q fever was first described in 1935 by Edward Holbrook Derrick[24] in slaughterhouse workers in Brisbane, Queensland. The "Q" stands for "query" and was applied at a time when the causative agent was unknown; it was chosen over suggestions of abattoir fever and Queensland rickettsial fever, to avoid directing negative connotations at either the cattle industry or the state of Queensland.[25]

The pathogen of Q fever was discovered in 1937, when Frank Macfarlane Burnet and Mavis Freeman isolated the bacterium from one of Derrick's patients.[26] It was originally identified as a species of Rickettsia. H.R. Cox and Gordon Davis elucidated the transmission when they isolated it from ticks found in the US state of Montana in 1938.[27] It is a zoonotic disease whose most common animal reservoirs are cattle, sheep, and goats. Coxiella burnetii – named for Cox and Burnet – is no longer regarded as closely related to the Rickettsiae, but as similar to Legionella and Francisella, and is a proteobacterium.[citation needed]

Society and culture

An early mention of Q fever was important in one of the early Dr. Kildare films (1939, Calling Dr. Kildare). Kildare's mentor Dr. Gillespie (Lionel Barrymore) tires of his protégé working fruitlessly on "exotic diagnoses" ("I think it's Q fever!") and sends him to work in a neighborhood clinic, instead.[28][29]

Q fever was also highlighted in an episode of the U.S. television medical drama House ("The Dig", season seven, episode 18).[citation needed]

Biological warfare

C  burnetii has been developed as a biological weapon.[30]

The United States investigated it as a potential biological warfare agent in the 1950s, with eventual standardization as agent OU. At Fort Detrick and Dugway Proving Ground, human trials were conducted on Whitecoat volunteers to determine the median infective dose (18 MICLD50/person i.h.) and course of infection. The Deseret Test Center dispensed biological Agent OU with ships and aircraft, during Project 112 and Project SHAD.[31] As a standardized biological, it was manufactured in large quantities at Pine Bluff Arsenal, with 5,098 gallons in the arsenal in bulk at the time of demilitarization in 1970.

C. burnetii is currently ranked as a "category B" bioterrorism agent by the CDC.[32] It can be contagious, and is very stable in aerosols in a wide range of temperatures. Q fever microorganisms may survive on surfaces up to 60 days. It is considered a good agent in part because its ID50 (number of bacilli needed to infect 50% of individuals) is considered to be one, making it the lowest known.[dubious ]

Other animals

Cattle, goats, and sheep are most commonly infected, and can serve as a reservoir for the bacteria. Q fever is a well-recognized cause of abortions in ruminants and pets. C. burnetii infection in dairy cattle has been well documented and its association with reproductive problems in these animals has been reported in Canada, the US, Cyprus, France, Hungary, Japan, Switzerland, and Germany.[33] For instance, in a study published in 2008,[34] a significant association has been shown between the seropositivity of herds and the appearance of typical clinical signs of Q fever, such as abortion, stillbirth, weak calves, and repeat breeding. Moreover, experimental inoculation of C. burnetii in cattle induced not only respiratory disorders and cardiac failures (myocarditis), but also frequent abortions and irregular repeat breedings.[35]

References

  1. 1.0 1.1 1.2 1.3 "Epidemiology and Statistics | Q Fever". CDC. May 15, 2024. Archived from the original on September 27, 2024. Retrieved September 26, 2024.
  2. 2.0 2.1 2.2 National Organization for Rare Disorders (2003). "Q Fever". NORD Guide to Rare Disorders. Lippincott, Williams & Wilkins. p. 293. ISBN 978-0-7817-3063-1.
  3. Beare, Paul A.; Samuel, James E.; Howe, Dale; Virtaneva, Kimmo; Porcella, Stephen F.; Heinzen, Robert A. (April 2006). "Genetic diversity of the Q Fever Agent, Coxiella burnetii, Assessed by Microarray-Based Whole-Genome Comparisons". Journal of Bacteriology. 188 (7): 2309–2324. doi:10.1128/JB.188.7.2309-2324.2006. PMC 1428397. PMID 16547017. Retrieved September 26, 2024.
  4. "Q fever | About the disease". Genetic and Rare Diseases Information Center. September 2024. Archived from the original on July 14, 2024. Retrieved September 26, 2024.
  5. "About Q fever". CDC. May 15, 2024. Archived from the original on September 13, 2024. Retrieved September 26, 2024.
  6. 6.0 6.1 Centers for Disease Control and Prevention (2012). "Q Fever". In Brunette, Gary W., MD, MS; et al. (eds.). CDC Health Information for International Travel 2012. Oxford University Press. pp. 270–271. ISBN 978-0-19-976901-8. ISSN 0095-3539. Retrieved September 26, 2024.{{cite book}}: CS1 maint: multiple names: editors list (link)
  7. Kuhne, F.; Morlat, P.; Riss, I.; Dominguez, M.; Hostyn, P.; Carniel, N.; Paix, M.A.; Aubertin, J.; Raoult, D.; Le Rebeller, M.J. (1992). "La vascularite A29, B12, est-elle déclenchée par l'agent de la fièvre Q? (Coxiella burnetii)" [Is A29, B12 vasculitis caused by the Q fever agent? (Coxiella burnetii)]. Journal Francais d'Ophtalmologie (in français). 15 (5): 315–321. ISSN 0181-5512. OCLC 116712679. PMID 1430809.
  8. Karakousis, Petros C.; Trucksis, Michele; Dumler, J. Stephen (June 2006). "Chronic Q Fever in the United States". Journal of Clinical Microbiology. 44 (6): 2283–2287. doi:10.1128/JCM.02365-05. PMC 1489455. PMID 16757641. Retrieved September 26, 2024.
  9. Maurin, M.; Raoult, D. (October 1, 1999). "Q fever". Clinical Microbiology Reviews. 12 (4): 518–553. doi:10.1128/CMR.12.4.518. PMC 88923. PMID 10515901. Retrieved September 26, 2024.
  10. La Scola, Bernard (October 2002). "Current laboratory diagnosis of Q fever". Seminars in Pediatric Infectious Diseases. 13 (4): 257–262. doi:10.1053/spid.2002.127199. PMID 12491231.
  11. 11.0 11.1 11.2 11.3 "Clinical and Laboratory Diagnosis for Q Fever". CDC. May 15, 2024. Archived from the original on September 27, 2024. Retrieved September 26, 2024.
  12. van de Veerdonk, Frank Leo; Schneeberger, Peter Martin (April 1, 2006). "Patient with Fever and Diarrhea". Clinical Infectious Diseases. 42 (7): 1051–1052. doi:10.1086/501027. Archived from the original on September 28, 2024. Retrieved September 27, 2024.
  13. "Q fever Vaccine" (PDF). CSL. 17 January 2014. Archived from the original (PDF) on 9 March 2017. Retrieved 11 July 2015.
  14. "USCF communicable disease prevention program animal exposure surveillance program" (PDF). Archived from the original (PDF) on 2007-07-01. Retrieved 2007-05-08.
  15. "Australian Q Fever Register". AusVet. Retrieved 12 February 2016.
  16. Mckenzie, Bex (2019-11-20). "Q-Fever Vaccinations". Faculty of Veterinary and Agricultural Sciences. Retrieved 2020-07-11.
  17. Camuset, Ph.; Remmy, D. (2008). "Q Fever (Coxiella Burnetii) Eradication in a Dairy Herd by using Vaccination with a Phase 1 Vaccine (Coxevac®, Ceva S.A.)". Proceedings of the XXV Jubilee World Buiatrics Congress. Budapest: Magyar Állatorvosol Lapja: 80–81. OCLC 324998468.
  18. Hogerwerf, L; Van Den Brom, R; Roest, HI; Bouma, A; Vellema, P; Pieterse, M; Dercksen, D; Nielen, M (2011). "Reduction of Coxiella burnetii prevalence by vaccination of goats and sheep, the Netherlands". Emerging Infectious Diseases. 17 (3): 379–386. doi:10.3201/eid1703.101157. PMC 3166012. PMID 21392427.
  19. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A (2007). "Managing Q fever during pregnancy: The benefits of long-term Cotrimoxazole therapy". Clin Infect Dis. 45 (5): 548–555. doi:10.1086/520661. PMID 17682987.
  20. Cutler SJ, Bouzid M, Cutler RR (April 2007). "Q fever". J. Infect. 54 (4): 313–8. doi:10.1016/j.jinf.2006.10.048. PMID 17147957.
  21. Domingo P, Muñoz C, Franquet T, Gurguí M, Sancho F, Vazquez G (October 1999). "Acute Q fever in adult patients: report on 63 sporadic cases in an urban area". Clin. Infect. Dis. 29 (4): 874–9. doi:10.1086/520452. PMID 10589906.
  22. Dupuis G, Petite J, Péter O, Vouilloz M (June 1987). "An important outbreak of human Q fever in a Swiss Alpine valley". Int J Epidemiol. 16 (2): 282–7. doi:10.1093/ije/16.2.282. PMID 3301708.
  23. "Q fever: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2018-04-17.
  24. Derrick, E. H. (August 1937). "'Q' Fever a new fever entity: clinical features. diagnosis, and laboratory investigation". Medical Journal of Australia. 2 (8): 281–299. doi:10.5694/j.1326-5377.1937.tb43743.x.
  25. Joseph E. McDade (1990). "Historical aspects of Q Fever". In Thomas J. Marrie (ed.). Q Fever, Volume I: The Disease. CRC Press. p. 8. ISBN 978-0-8493-5984-2.
  26. Burnet, F. M.; Freeman, M. (1 July 1983). "Experimental Studies on the Virus of 'Q' Fever". Clinical Infectious Diseases. 5 (4): 800–808. doi:10.1093/clinids/5.4.800. PMID 6194551.
  27. Davis, Gordon E.; Cox, Herald R.; Parker, R. R.; Dyer, R. E. (1938). "A Filter-Passing Infectious Agent Isolated from Ticks". Public Health Reports. 53 (52): 2259. doi:10.2307/4582746. JSTOR 4582746.
  28. "Calling Dr. Kildare". Movie Mirrors Index. Retrieved 30 April 2013.
  29. Kalisch, Philip A; Kalisch, Beatrice J (September 1985). "When Americans called for Dr. Kildare: images of physicians and nurses in the Dr. Kildare and Dr. Gillespie movies, 1937-1947" (PDF). Medical Heritage. 1 (5): 348–363. PMID 11616027.
  30. Madariaga MG, Rezai K, Trenholme GM, Weinstein RA (November 2003). "Q Fever: A biological weapon in your backyard". Lancet Infect Dis. 3 (11): 709–21. doi:10.1016/S1473-3099(03)00804-1. PMID 14592601.
  31. Deseret Test Center, Project SHAD, Shady Grove revised fact sheet[permanent dead link]
  32. Seshadri R, Paulsen IT, Eisen JA, et al. (April 2003). "Complete genome sequence of the Q-fever pathogen Coxiella burnetii". Proc. Natl. Acad. Sci. U.S.A. 100 (9): 5455–60. Bibcode:2003PNAS..100.5455S. doi:10.1073/pnas.0931379100. PMC 154366. PMID 12704232.
  33. To, Ho; Sakai, Ritsuko; Shirota, Kazutoshi; Kano, Chiaki; Abe, Satomi; Sugimoto, Tomoaki; Takehara, Kazuaki; Morita, Chiharu; Takashima, Ikuo; Maruyama, Tsutomu; Yamaguchi, Tsuyoshi; Fukushi, Hideto; Hirai, Katsuya (April 1998). "Coxiellosis in domestic and wild birds from Japan". Journal of Wildlife Diseases. 34 (2): 310–316. doi:10.7589/0090-3558-34.2.310. PMID 9577778. S2CID 36217068.
  34. Czaplicki, Guy; Houtain, Jean-Yves; Mullender, Cédric; Porter, Sarah Rebecca; Humblet, Marie-France; Manteca, Christophe; Saegerman, Claude (June 2012). "Apparent prevalence of antibodies to Coxiella burnetii (Q fever) in bulk tank milk from dairy herds in southern Belgium". The Veterinary Journal. 192 (3): 529–531. doi:10.1016/j.tvjl.2011.08.033. hdl:2268/103290. PMID 21962829.
  35. Plommet, M; Capponi, M; Gestin, J; Renoux, G (1973). "Fièvre Q expérimentale des bovins" [Experimental Q fever in cattle]. Annales de Recherches Vétérinaires (in français). 4 (2): 325–346.